Psychoactive Medication Use in Pediatric Heart Transplant Recipients: An Assessment of Prevalence, Risk Factors, and Outcomes

20260 citationsJournal Articlebronze Open Access

Authors

Jenna Schauer · Morgan Stanley Children's Hospital

Othman A. Aljohani · UCSF Benioff Children's Hospital

Ryan Cantor · Kirklin Clinic

A Fraser · Morgan Stanley Children's Hospital

Firezer Haregu · University of Virginia Children's Hospital

Kyle D. Hope · Texas Children's Hospital

James K Kirklin

Abstract

A significant proportion of pediatric heart transplant recipients take psychoactive medications. Psychoactive medication usage is associated with worse long-term outcomes including graft loss and coronary artery disease.

Topics & Keywords

Transplantation: Methods and Outcomes Renal Transplantation Outcomes and Treatments Heart Failure Treatment and Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Pediatric Transplantation

Volume 30, Issue 2, pp. e70272-e70272

DOI: 10.1111/petr.70272

Field-Weighted Citation Impact: 0.00